Grace Therapeutics, Inc. (GRCE)
Market Open
26 Oct, 06:41 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 77
-0.16
-8.2902%
$
32.22M Market Cap
- P/E Ratio
- Div Yield
446,181 Volume
0 Eps
$ 1.93
Previous Close 
Want to track GRCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.05 |
| | | - | - |
| | | - | - |
GRCE Earnings Reports FAQ
What is the earnings per share (EPS) for GRCE?
The current EPS is 0.
What is the company's earnings growth rate?
Grace Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Grace Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Grace Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GRCE at this time, as Grace Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
